Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula de Melo Campos

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Revista Brasileira De Hematologia E Hemoterapia|August 14, 2016
Primary myelofibrosis: current therapeutic optionsPaula de Melo Campos
Revista Brasileira De Hematologia E Hemoterapia|December 3, 2014
Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something elsePaula de Melo Campos, Fabiola Traina, Irene Lorand-Metze, et al.
Hematology, Transfusion and Cell Therapy|May 16, 2025
Iron overload is not the same everywhere: Particularities of iron-metabolism gene mutations in Brazil and a proposal for the investigation and management of iron overload in this populationPaula de Melo Campos, Ana Carolina Toreli, Dulcinéia Martins de Albuquerque, et al.
Hematology, Transfusion and Cell Therapy|August 21, 2022
Early integration of palliative care in hematology: an urgency for patients, a challenge for physiciansLaura Ferreira de Mesquita Ferraz, Amanda Pifano Soares Ferreira, Tânia Vannucci Vaz Guimarães, et al.
Leukemia Research|February 3, 2007
Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndromePaula de Melo Campos, Fabíola Traina, Adriana da Silva Santos Duarte, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 9, 2018
The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiationIsabella Barbutti, João Agostinho Machado-Neto, Vanessa Cristina Arfelli, et al.
Scientific Reports|January 14, 2017
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changesMatheus Rodrigues Lopes, João Kleber Novais Pereira, Paula de Melo Campos, et al.
The American Journal of Hospice & Palliative Care|October 7, 2022
Hematologic Malignancies Patients Face High Symptom Burden and Are Lately Referred to Palliative Consultation: Analysis of a Single Center ExperienceRaissa P C Ebert, Mariana M Magnus, Pedro Toro, et al.
Leukemia Research|December 21, 2013
Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cellsJoão Agostinho Machado-Neto, Paula de Melo Campos, Patricia Favaro, et al.
Hematology, Transfusion and Cell Therapy|May 8, 2024
Investigation of BMP6 mutations in Brazilian patients with iron overloadAna Carolina Mourão Toreli, Isabella Toni, Dulcinéia Martins de Albuquerque, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Revista Brasileira De Hematologia E Hemoterapia|August 14, 2016
Primary myelofibrosis: current therapeutic optionsPaula de Melo Campos
Revista Brasileira De Hematologia E Hemoterapia|December 3, 2014
Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something elsePaula de Melo Campos, Fabiola Traina, Irene Lorand-Metze, et al.
Hematology, Transfusion and Cell Therapy|May 16, 2025
Iron overload is not the same everywhere: Particularities of iron-metabolism gene mutations in Brazil and a proposal for the investigation and management of iron overload in this populationPaula de Melo Campos, Ana Carolina Toreli, Dulcinéia Martins de Albuquerque, et al.
Hematology, Transfusion and Cell Therapy|August 21, 2022
Early integration of palliative care in hematology: an urgency for patients, a challenge for physiciansLaura Ferreira de Mesquita Ferraz, Amanda Pifano Soares Ferreira, Tânia Vannucci Vaz Guimarães, et al.
Leukemia Research|February 3, 2007
Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndromePaula de Melo Campos, Fabíola Traina, Adriana da Silva Santos Duarte, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 9, 2018
The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiationIsabella Barbutti, João Agostinho Machado-Neto, Vanessa Cristina Arfelli, et al.
Scientific Reports|January 14, 2017
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changesMatheus Rodrigues Lopes, João Kleber Novais Pereira, Paula de Melo Campos, et al.
The American Journal of Hospice & Palliative Care|October 7, 2022
Hematologic Malignancies Patients Face High Symptom Burden and Are Lately Referred to Palliative Consultation: Analysis of a Single Center ExperienceRaissa P C Ebert, Mariana M Magnus, Pedro Toro, et al.
Leukemia Research|December 21, 2013
Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cellsJoão Agostinho Machado-Neto, Paula de Melo Campos, Patricia Favaro, et al.
Hematology, Transfusion and Cell Therapy|May 8, 2024
Investigation of BMP6 mutations in Brazilian patients with iron overloadAna Carolina Mourão Toreli, Isabella Toni, Dulcinéia Martins de Albuquerque, et al.
Pageof 4